Archives

Visionweb and Neurolens Collaborate to Increase Prism Specificity

Visionweb and Neurolens Collaborate to Increase Prism Specificity

Through VisionWeb’s ordering platform, prism can now be entered to the 1/100th prism diopter

Ongoing research from a myriad of sources has indicated that at least two out of three patients experience the symptoms of eye misalignment; and the rapid acceleration in remote working and learning over the past two years has undoubtedly led to a rise in this figure. Optical prisms are one of the most commonly employed treatment modalities to correct these binocular vision issues. As such, technological innovations in this space will become increasingly important to the future of eyecare. In order to ensure that eyecare providers are able to meet these growing challenges, Neurolens and VisionWeb have worked together to expand the prism field from 1/4th prism diopter to 1/100th prism diopter when placing orders through VisionWeb’s ordering platform.

“At Neurolens, we strongly believe that the eyecare industry must evolve beyond visual acuity to own the visual comfort space as well,” says Pierre Bertrand, Chief Executive Officer of Neurolens. “A large and growing percentage of the population is suffering from the symptoms of binocular vision issues—some on a daily basis—and Neurolenses provide proven relief for these patients. We are proud to collaborate with an industry leader like VisionWeb to ensure that eyecare providers can prescribe optical prism to the specificity required to meet the needs of today’s patients.”

Read More: Green Valley Obtains IND Approval from US FDA for Sodium Oligomannate’s Global Phase II Clinical Trial in Treating Parkinson’s Disease

This expanded prism range will allow Neurolens providers to take advantage of the highly accurate measurements from the Neurolens Measurement Device (NMD) and Neurolens Measurement Device, Gen 2 (NMD2) and prescribe precise prism measurements for their patients. “We are learning more every day about how small amounts of prism can create tremendous symptom relief for patients,” says Vivek Labhishetty BSc Optometry, MSc, PhD, Director of Clinical Research for Neurolens. “This creates an imperative to ensure prism measurements can be entered with a high degree of specificity to maximize the number of patients that can be helped by this technology.”

Mike Bonacci, Director of Integrations at VisionWeb says, “We are on a mission to make it easier for people in the eyecare industry to do their jobs, and we will continue to pioneer technology that enables eyecare providers to more efficiently conduct business and meet the needs of their patients. This development sends yet another signal that VisionWeb will make every effort to remain on the forefront of emerging trends in practice management and patient care.”

Read More: China SXT Pharma Adds TCMP Products; Announces Growth of Production Capacity